Coherus Oncology, Inc. (CHRS) (CIK 0001512762) CORRESP
A CORRESP letter is the company's written reply to the SEC during a filing review. Responses include accounting position arguments, restatement assessments, and clarifying disclosures. Released to EDGAR alongside the SEC's UPLOAD letters.
Key facts
- Accession number
- 0001104659-25-118941
- Form
- CORRESP
- Filer
- Coherus Oncology, Inc. (CHRS) (CIK 0001512762)
- CIK
- 0001512762
- Ticker
- CHRS
- Filed
- 2025-12-05
- SIC industry
- 2836
- HQ
- Redwood City, CA
Primary source
PDF letter: https://www.sec.gov/Archives/edgar/data/1512762/000110465925118941/filename1.htm
EDGAR review index: browse all UPLOAD/CORRESP for this filer ↗